A universal vaccine that could bring an end to the COVID-19 pandemic is now in development at the Garvan Institute of Medical Research.
Researchers will investigate treatment measures for COVID-19 infection and the aerosol transmission of SARS-COV-2.
Director of the Institute, Professor Pall Thordarson says the RNA revolution is just getting started.
UNSW Sydney professor Pall Thordarson shares the chemical reaction that took him from working on a farm in Iceland to running the first RNA institute in Australia.
It’s hoped NSW’s first RNA pilot manufacturing facility will spearhead a commercialised RNA industry in the state.
Beyond fighting pandemics with mRNA vaccines, there is significant potential to treat cancer, genetic and autoimmune diseases.
The UNSW RNA Institute will position Australia as a leader in the global research effort to combat emerging vaccine-resistant viruses, such as COVID-19 variants.